OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
January 01, 2023
Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.
December 01, 2022
Science news can be just so weird, or weirdly useful, that everything else recedes as we ponder whether it is true and what consequences it might bring.
November 01, 2022
Next year's "FDA Voices" series will cover core topics FDA staff are prioritizing.
October 01, 2022
The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.
September 01, 2022
While the cost of certain medicines are alarmingly high, they can be considered a bargain measured against a lifetime of traditional costs.
August 01, 2022
How can we fix the quality manufacturing issues that come with product shortages?
July 01, 2022
Systemic inefficiencies in the pharmaceutical industry undermine problem-solving efforts.
June 01, 2022
AI could provide solutions to critical manufacturing inefficiencies.
May 01, 2022
Spring has returned, and with it comes INTERPHEX.
April 01, 2022
Advances in pharmaceutical neuroscience present an opportunity for pharmaceutical companies to stay ahead of the curve.